Medical management of patients with brain tumors

被引:68
作者
Wen, PY
Marks, PW
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Neurol, Div Neuro Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Hematol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA
关键词
D O I
10.1097/00001622-200205000-00008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most common medical problems in brain tumor patients involve the management of seizures, peritumoral edema, medication side effects, and venous thromboembolism. Despite the importance of these issues, there are very few studies specifically addressing them. Nonetheless, there has been some progress in recent years. There is increasing evidence that brain tumor patients who have not had a seizure do not benefit from prophylactic antiepileptic medications. Patients taking corticosteroids are at greater risk of Pneumocystis carinii pneumonia and may benefit from prophylactic therapy. There is also growing evidence suggesting that anticoagulation may be more effective than inferior vena cava filtration devices for treating venous thromboembolism in brain tumor patients and that the risk of hemorrhage with anticoagulation is relatively small. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 129 条
[51]   The thrombophilic state in cancer patients [J].
Gouin-Thibault, I ;
Achkar, A ;
Samama, MM .
ACTA HAEMATOLOGICA, 2001, 106 (1-2) :33-42
[52]  
GROSSMAN SA, 1989, AM J MED, V87, P505
[53]   Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants [J].
Grossman, SA ;
Hochberg, F ;
Fisher, J ;
Chen, TL ;
Kim, L ;
Gregory, R ;
Grochow, LB ;
Piantadosi, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (02) :118-126
[54]  
Hamada K, 1996, CANCER, V77, P1877, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1877::AID-CNCR18>3.0.CO
[55]  
2-X
[56]  
Hariharan S, 2000, NEUROLOGY, V54, pA12
[57]   EFFECT OF DEXAMETHASONE ON BLOOD-BRAIN-BARRIER IN THE NORMAL MOUSE [J].
HEDLEYWHYTE, ET ;
HSU, DW .
ANNALS OF NEUROLOGY, 1986, 19 (04) :373-377
[58]   Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats - Involvement of the glucocorticoid receptor and vascular permeability factor [J].
Heiss, JD ;
Papavassiliou, E ;
Merrill, MJ ;
Nieman, L ;
Knightly, JJ ;
Walbridge, S ;
Edwards, NA ;
Oldfield, EH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06) :1400-1408
[59]   PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH PRIMARY BRAIN-TUMORS [J].
HENSON, JW ;
JALAJ, JK ;
WALKER, RW ;
STOVER, DE ;
FELS, AOS .
ARCHIVES OF NEUROLOGY, 1991, 48 (04) :406-409
[60]   Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety [J].
Hirsh, J ;
Warkentin, TE ;
Shaughnessy, SG ;
Anand, SS ;
Halperin, JL ;
Raschke, R ;
Granger, C ;
Ohman, EM ;
Dalen, JE .
CHEST, 2001, 119 (01) :64S-94S